Engineered liposomes in interventional theranostics of solid tumors

N Kommineni, R Chaudhari, J Conde… - ACS Biomaterials …, 2023 - ACS Publications
Engineered liposomal nanoparticles have unique characteristics as cargo carriers in cancer
care and therapeutics. Liposomal theranostics have shown significant progress in preclinical …

Fecal microbiota transplantation in liver cirrhosis

A Boicean, V Birlutiu, C Ichim, O Brusnic, DM Onișor - Biomedicines, 2023 - mdpi.com
The human gastrointestinal tract houses a diverse array of probiotic and pathogenic bacteria
and any alterations in this microbial composition can exert a significant influence on an …

GAS5: A pivotal lncRNA in diabetes mellitus pathogenesis and management

KS Alharbi - Pathology-Research and Practice, 2024 - Elsevier
The long non-coding RNA (lncRNA), GAS5, has garnered significant attention recently for its
multifaceted involvement in cellular processes, particularly within the context of diabetes …

Microbiota and recurrent pregnancy loss (RPL); more than a simple connection

JV Garmendia, CV De Sanctis, M Hajdúch… - …, 2024 - pmc.ncbi.nlm.nih.gov
Recurrent Pregnancy Loss (RPL) affects 1–2% of women, and its triggering factors are
unclear. Several studies have shown that the vaginal, endometrial, and gut microbiota may …

Lactobacillus rhamnosus ameliorates acne vulgaris in SD rats via changes in gut microbiota and associated tryptophan metabolism

Y Huang, Y Huang, D **a, L Liu, X **ong… - Frontiers in …, 2024 - frontiersin.org
Background The depletion of beneficial bacteria in the gut has been found in patients with
acne vulgaris, and in previous studies, the supplement of Lactobacillus rhamnosus led to the …

Polysaccharide-fecal microbiota-based colon-targeted self-nanoemulsifying drug delivery system of curcumin for treating polycystic ovarian syndrome

L Corrie, H Singh, M Gulati, S Vishwas… - Naunyn-Schmiedeberg's …, 2024 - Springer
The gut microbiome is involved in the pathogenesis of many diseases including polycystic
ovarian syndrome (PCOS). Modulating the gut microbiome can lead to eubiosis and …

Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome

P Zhou, P Feng, B Liao, L Fu, H Shan, C Cao… - Journal of Ovarian …, 2024 - Springer
Polycystic ovary syndrome (PCOS) is a common reproductive and metabolic condition in
women of childbearing age and a major cause of anovulatory infertility. The pathophysiology …

[HTML][HTML] Impact of Gut Microbiota and SCFAs in the Pathogenesis of PCOS and the Effect of Metformin Therapy

E Kukaev, E Kirillova, A Tokareva, E Rimskaya… - International Journal of …, 2024 - mdpi.com
Polycystic ovary syndrome (PCOS) is a complex disorder that impacts both the endocrine
and metabolic systems, often resulting in infertility, obesity, insulin resistance, and …

Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?

PS Kumbhar, R Chavan, S Darekar, K Kolekar… - Naunyn-Schmiedeberg's …, 2024 - Springer
Polycystic ovarian syndrome (PCOS) is one of the chief causes of infertility in women of
reproductive age. Several drugs belonging to the oral contraceptive class have been …

Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis

J He, X Ruan, J Li - Frontiers in Endocrinology, 2024 - frontiersin.org
Background Obstructive sleep apnea-hypopnea syndrome (OSAHS) is correlated with
metabolic deterioration in patients experiencing polycystic ovary syndrome (PCOS). Women …